0
0.5
1
1.5
2+
Mortality
17%
Improvement
Relative Risk
Recovery
6%
Recovery, day 5
-8%
Discharge
7%
Ensovibep ACTIV-3/TICO LATE TREATMENT DB RCT
Is late treatment with ensovibep beneficial for COVID-19?
Double-blind RCT 485 patients in multiple countries (Jun - Nov 2021)
Lower mortality with ensovibep (not stat. sig., p=0.46)
c19early.org
Barkauskas et al., Annals of Internal .., Aug 2022
Favors ensovibep
Favors control